- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
April 15, 2024Robins Kaplan Named to 2024 BTI Client Service A-Team
-
April 9, 2024Robins Kaplan LLP Files Complaint Against Social Media Giants Meta, Snap, TikTok on Behalf of Spirit Lake Nation, Menominee Indian Tribe of Wisconsin
-
April 8, 2024Tara Sutton, Emily Tremblay Shortlisted for Euromoney’s Women in Business Law Awards
-
April 24, 2024IP Leadership Executive Summit
-
April 24, 2024IP Odyssey: Navigating the Latest Developments in Intellectual Property Law
-
April 30, 2024Navigating Generational Dynamics
-
March 2024e-Commerce: Pitfalls and Protections
-
March 22, 2024‘In re Cellect’:
-
March 14, 2024How Many Cases Have You Tried to a Verdict?
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Key Decisions Affecting Drug and Device Litigation in the Last Year
American Bar Association
February 26, 2021
Remote
Related Professionals
Rayna E. Kessler
Partner
Start time: February 26, 2021 | 11:30 a.m. ET
Duration: 60 minutes
On Friday, February 26, 2021, Rayna Kessler co-presented in a webinar hosted by American Bar Association titled “Key Decisions Affecting Drug and Device Litigation in the Last Year.” The last 12 months have seen a number of cases with significant implications to pharmaceutical and medical device litigation in areas such as personal jurisdiction, preemption, and much more. This session will provide an overview of these and other key decisions impacting the drug and device landscape.
Rayna Kessler - American Bar Association
Learn More
Related Publications
March 2024
Tony Schrank: Advocating for Justice Beyond the Courtroom
Tony Schrank - The Robins Kaplan Justice Report
December 14, 2023
Lawdragon:
In Conversation with Tara Sutton, Head of The Mass Tort Practice at Robins Kaplan
In Conversation with Tara Sutton, Head of The Mass Tort Practice at Robins Kaplan
Tara Sutton - Lawdragon
July 27, 2023
Mallory Gives Plaintiffs a Better Shot at Justice
Rayna Kessler, Ethan Seidenberg - Law360
May 2023
Raoul Shah: Keeping Humanity and Compassion Close
The Robins Kaplan Justice Report
January 2023
Greta Wiessner: Making the Civil Rights Movement a Modern-Day Reality
The Robins Kaplan Justice Report
Related News
February 12, 2024
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.